We are live on
!
Find out more
MREO
Mereo BioPharma
MREO
MREO
63 hedge funds and large institutions have $24.9M invested in Mereo BioPharma in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
49% more call options, than puts
Call options by funds: $315K | Put options by funds: $212K
8.39% more ownership
Funds ownership: 38.98% → 47.37% (+8.4%)
4% less capital invested
Capital invested by funds: $25.8M → $24.9M (-$955K)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
10% less funds holding
Funds holding: 70 → 63 (-7)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
Holders
63
Holders Change
-7
Holders Change %
-10%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
15
Reduced
16
Closed
21
Calls
$315K
Puts
$212K
Net Calls
+$103K
Net Calls Change
-$675K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$3.51M |
| 2 |
DCM
Defilade Capital Management
Emeryville,
California
|
+$3.24M |
| 3 |
NM
Newtyn Management
New York
|
+$2.94M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.37M |
| 5 |
Millennium Management
New York
|
+$1.49M |
Top Sellers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.54M |
| 2 |
6CM
683 Capital Management
New York
|
-$1.3M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$771K |
| 4 |
UBS AM
Chicago,
Illinois
|
-$735K |
| 5 |
MAM
Monaco Asset Management
Monaco
|
-$661K |
